Cherry Hill Mortgage (CHMI): After the Fall, Is a Rebound Brewing?

November 01, 2025, 07:45 AM EDT

Whispers from the Wire: A Downgrade Casts a Shadow

The recent news flow for Cherry Hill Mortgage has been a mixed bag, but one item clearly stands out. On October 13th, Janney Montgomery Scott cut their rating on the stock from Buy to Neutral. A downgrade like this often spooks investors, suggesting an analyst sees less opportunity for growth in the near future. This news arrived while the stock was already under considerable pressure, likely adding to the negative sentiment.

Separately, the company announced it will release its third-quarter financial results on November 6th. This is a standard procedural announcement, but it puts a firm date on the calendar when investors will get a hard look at the company's performance, including its revenue and profitability. All eyes will be on that report.

The September Plunge: A Look Back at the Chart

The price history for CHMI tells a dramatic story of a stock that fell off a cliff. After a steady climb through August that took the price from around $2.60 to a peak of $2.90 by mid-September, the floor gave out.

On September 16th, the stock experienced a massive sell-off. It closed at $2.90 the day before and plummeted to $2.52 on enormous trading volume. That single day erased weeks of gains and marked a sharp reversal in fortune. Following that drop, the stock continued to bleed lower through the end of October, eventually finding what appears to be a floor near its 52-week low of $2.25. The last few trading days show the stock attempting to stabilize in the $2.30s, but the damage from that September event still defines the chart.

A Tug-of-War: The Battle Between a Bounce and Headwinds

The data presents a fascinating conflict. On one hand, the fundamental picture is challenging. The company faces shrinking revenue (-20.4% growth), a negative return on equity, and a very high debt-to-equity ratio of over 530. These are serious red flags. One AI forecast even points to a potential long-term price target of $1.87, which would mean more pain ahead.

Yet, a compelling case for a short-term bounce is also emerging.

• The stock is trading right at a technical support level, a price where buyers have historically shown interest.
• A short-term momentum indicator (the MACD) recently flashed a bullish signal, suggesting the intense selling pressure may be letting up.
• The stock appears cheap based on its P/E ratio of 2.7, which is well below the industry average.
• Short-term AI predictions are optimistic, forecasting gains of 2.8%, 1.5%, and 2.2% over the next three trading days.

This is a classic battle. Grim fundamentals are wrestling with technical signals that suggest the stock is oversold and due for a potential recovery rally.

The Bottom Line

For a value-focused investor with a medium-term horizon (1-3 months), CHMI presents a high-risk, speculative opportunity. The company's financial health is a major concern, and the September price collapse cannot be ignored.

However, for those willing to stomach the risk, the technicals suggest a potential trade is setting up. The data points to possible entry points between $2.34 and $2.38. The idea here is to bet on a technical bounce from a deeply beaten-down level.

Given the underlying weakness, a strict exit strategy is essential. A stop-loss order around $2.10 could help manage losses if the stock breaks below its recent support. If a bounce does materialize, a take-profit target near $2.53--the level where the stock fell on that brutal day in September--seems like a reasonable first objective.

Disclaimer: This report is for informational purposes only and does not constitute financial, investment, or trading advice. The analysis is based on the data provided and is not a guarantee of future performance. All investing involves risk, including the possible loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.